Kangmei Pharmaceutical Statistics

Total Valuation

SHA:600518 has a market cap or net worth of CNY 29.53 billion. The enterprise value is 29.01 billion.

Market Cap	29.53B
Enterprise Value	29.01B

Important Dates

The next estimated earnings date is Saturday, April 19, 2025.

Earnings Date	Apr 19, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:600518 has 13.86 billion shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	13.86B
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-42.35%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	11.15%
Float	10.02B

Valuation Ratios

The trailing PE ratio is 115.56.

PE Ratio	115.56
Forward PE	n/a
PS Ratio	5.66
PB Ratio	4.19
P/TBV Ratio	4.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 48.35, with an EV/FCF ratio of -57.70.

EV / Earnings	113.51
EV / Sales	5.56
EV / EBITDA	48.35
EV / EBIT	104.48
EV / FCF	-57.70

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.03.

Current Ratio	1.43
Quick Ratio	0.77
Debt / Equity	0.03
Debt / EBITDA	0.36
Debt / FCF	-0.43
Interest Coverage	5.02

Financial Efficiency

Return on equity (ROE) is 3.71% and return on invested capital (ROIC) is 2.41%.

Return on Equity (ROE)	3.71%
Return on Assets (ROA)	1.21%
Return on Invested Capital (ROIC)	2.41%
Return on Capital Employed (ROCE)	2.99%
Revenue Per Employee	1.18M
Profits Per Employee	57,960
Employee Count	4,409
Asset Turnover	0.36
Inventory Turnover	1.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.04% in the last 52 weeks. The beta is 0.54, so SHA:600518's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+12.04%
50-Day Moving Average	2.33
200-Day Moving Average	2.07
Relative Strength Index (RSI)	33.65
Average Volume (20 Days)	265,309,017

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:600518 had revenue of CNY 5.21 billion and earned 255.55 million in profits. Earnings per share was 0.02.

Revenue	5.21B
Gross Profit	665.09M
Operating Income	277.63M
Pretax Income	262.01M
Net Income	255.55M
EBITDA	545.02M
EBIT	277.63M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 773.59 million in cash and 215.93 million in debt, giving a net cash position of 557.66 million or 0.04 per share.

Cash & Cash Equivalents	773.59M
Total Debt	215.93M
Net Cash	557.66M
Net Cash Per Share	0.04
Equity (Book Value)	7.08B
Book Value Per Share	0.51
Working Capital	2.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -413.90 million and capital expenditures -88.84 million, giving a free cash flow of -502.74 million.

Operating Cash Flow	-413.90M
Capital Expenditures	-88.84M
Free Cash Flow	-502.74M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 12.76%, with operating and profit margins of 5.33% and 4.90%.

Gross Margin	12.76%
Operating Margin	5.33%
Pretax Margin	5.03%
Profit Margin	4.90%
EBITDA Margin	10.45%
EBIT Margin	5.33%
FCF Margin	n/a

Dividends & Yields

SHA:600518 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	0.87%
FCF Yield	-1.70%

Stock Splits

The last stock split was on June 16, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jun 16, 2015
Split Type	Forward
Split Ratio	2

Scores

SHA:600518 has an Altman Z-Score of 0.43. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.43
Piotroski F-Score	n/a